1st Quarter - Report

SANOFI US SERVICES INC. for SANOFI US SERVICES INC

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$1,800,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report (this page) Apr 18, 2013 $1,800,000 Replaced
1st Quarter - Amendment Jul 18, 2013 $1,800,000 Yes

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Extension of the U.S. R&D tax credit; adding quadrivalent influenza vaccine formulation to the Vaccine Injury Compensation Program.

Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.

LobbyistCovered position, as disclosed
SEAN CALLINICOS —
EDWARD GREISSING —
PATRICK MAYES MCLAIN —
ANN TAYLOR —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Copyright/Patent/Trademark CPT

General issues related to settlements of patent infringement litigation; international intellectual property issues.

Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.

LobbyistCovered position, as disclosed
SEAN CALLINICOS —
TIMOTHY CLARK —
EDWARD GREISSING —
PATRICK MAYES MCLAIN —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Economics/Economic Development ECN

General issues related to foreign direct investment in the United States.

Foreign entity interest: Sanofi SA, the foreign parent corporation of Sanofi US Services Inc.

LobbyistCovered position, as disclosed
EDWARD GREISSING —
PATRICK MAYES MCLAIN —
ANN TAYLOR —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Health Issues HCR

S. 77 "Prescription Drug and Health Improvement Act of 2013" - all provisions; S117, "Medicare Prescription Drug Price Negotiation Act of 2013" - all provisions; issues related to the continued over-the-counter availability of allergy, cough and cold medicines that contain pseudoephedrine; education and awareness of the 2012-2013 influenza season; education and awareness of pandemic and biodefense funding; education and awareness of dengue; FDA funding; reauthorization of Pandemic and All HazardsPreparation Act; general issues related to the importation of pharmaceutical products; issues related to chronic disease treatment adherence with the CMS Innovation Center; general issues related to School Access to Emergency Ephinephrine; and issues related to the data exclusivity period for generic biologics.

Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.

LobbyistCovered position, as disclosed
SEAN CALLINICOS —
TIMOTHY CLARK —
MARYANNE DOLBEARE DUNLAP —
EDWARD GREISSING —
PATRICK MAYES MCLAIN —
AMY L REDL —
ANN TAYLOR —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Bills named: S. 77 (113th)

Medicare/Medicaid MMM

Issues related to changes to the Medicare Part B reimbursement of prescription drugs; issues related to coverage and reimbursement for those who are covered by the Medicaid program and the Medicare program, including the Part D prescription drug benefit; and general issues related to the Medicare Part D program.

Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.

LobbyistCovered position, as disclosed
TIMOTHY CLARK —
EDWARD GREISSING —
PATRICK MAYES MCLAIN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Animals ANI

Education and awareness regarding illegal compounding of veterinary drugs for animals; general issues related to the reauthorization of the Animal Drug User Fee Act; HR1150 "Preservation of Antibiotics for Medical Treatment Act of 2013"; HR820 "Delivering Antimicrobial Transparency in Animals Act of 2013."

Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.

LobbyistCovered position, as disclosed
MARYANNE DOLBEARE DUNLAP —
EDWARD GREISSING —
PATRICK MAYES MCLAIN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: H.R. 820 (113th), H.R. 1150 (113th)

Affiliated organisations

OrganisationLocation
SANOFI PASTEUR Swiftwater, PA, US

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.